Search for: "E Merck" Results 201 - 220 of 393
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
29 Jan 2018, 2:57 am
PREVIOUSLY ON NEVER TOO LATENever too Late 178 [week ending 14 January] A Merck-y appeal is remitted to the High Court | Into fashion law? [read post]
19 Nov 2021, 10:46 am by Rebecca Tushnet
Neurelis argued that the exemption to the anti-SLAPP law was specifically focused on overturning DuPont Merck Pharmaceutical Co. v. [read post]
31 Dec 2009, 7:19 am
The vote to issue the complaint was 3-0, with Commissioner William E. [read post]
1 Jul 2010, 9:32 am by Laurie Briggs
Senate Finance Committee’s ranking minority member, Senator Charles E. [read post]
15 Jun 2007, 7:52 am
Whether or not there were royalties coming, California researchers could do research on therapeutic cloning/embryonic stem cells without paying patent royalties to WARF because of the research exemption of 35 USC 271(e)(1), as further articulated in Merck v. [read post]
28 Feb 2013, 11:08 am by Doug Cornelius
The SEC argued for the benefit of the discovery rule, which had been used in Merck & Co. v. [read post]
28 Feb 2013, 11:08 am by Doug Cornelius
The SEC argued for the benefit of the discovery rule, which had been used in Merck & Co. v. [read post]
21 May 2007, 10:41 am
  The new Avandia article, "Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death", by Steven E. [read post]
4 Mar 2020, 7:11 am by Wim Vandenberghe
Several contributing partners have already expressed an interest in joining an applicant consortium, including AbbVie, Astellas, Bayer, E-Pharma, Enyo Pharma, IDbyDNA, Merck, Novartis, Special Product’s Line SpA and Takeda.[4] The deadline for submitting applications is March 31, 2020. [read post]
25 Jan 2007, 5:28 pm
Evidently, Maclachlan hasn't heard about 35 USC 271(e)(1) or Merck v. [read post]
3 Jun 2011, 9:28 am
 In the world of European trade marks, the admirable Laetitia Lagarde has been carrying the Class 46 team on her shoulders this week with some very useful summaries of General Court decisions on Community trade mark issues, including those arising from the (non)similarity of E-PLEX and EPILEX, here. [read post]
6 Sep 2011, 1:10 pm by Stephen Jenei
Classen argued that the district court erred in its application of §271(e)(1). [read post]
31 Jul 2016, 5:22 pm by Bill Marler
It has long been said that, in 1885, pioneering American veterinary scientist, Daniel E. [read post]
16 Aug 2015, 8:49 am by Bill Marler
The most common Salmonella serogroups are A, B, C, D, E, F, and G. [read post]